| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of Tolazoline |
| Disease Entry |
ICD 11 |
Status |
REF |
| Cerebrovascular disease |
8B2Z
|
Approved |
[2] |
| Pulmonary hypertension |
BB01
|
Approved |
[3] |
| Vascular disease |
BE2Z
|
Investigative |
[2] |
|
|
|
Tolazoline Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Dopamine D2 receptor (D2R)
|
TTEX248
|
DRD2_HUMAN
|
Antagonist
|
[5] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Estramustine |
| Disease Entry |
ICD 11 |
Status |
REF |
| Prostate cancer |
2C82.0
|
Approved |
[4] |
|
|
|
Estramustine Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Estramustine binding protein (EMBP)
|
TTSBFYK
|
NOUNIPROTAC
|
Binder
|
[6] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Estramustine Interacts with 1 DME Molecule(s)
| DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 3A4 (CYP3A4)
|
DE4LYSA
|
CP3A4_HUMAN
|
Metabolism
|
[7] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Estramustine Interacts with 1 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Keratin, type I cytoskeletal 18 (KRT18)
|
OTVLQFIP
|
K1C18_HUMAN
|
Increases Expression
|
[8] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|